Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Arrivent Biopharma Inc (AVBP)

Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 879,155
  • Shares Outstanding, K 33,697
  • Annual Sales, $ 0 K
  • Annual Income, $ -69,330 K
  • EBIT $ -94 M
  • EBITDA $ -94 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.78
  • Number of Estimates 4
  • High Estimate -0.72
  • Low Estimate -0.93
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.01 +4.32%
on 12/19/24
30.41 -14.19%
on 12/02/24
-1.32 (-4.82%)
since 11/20/24
3-Month
22.39 +16.53%
on 09/23/24
36.37 -28.27%
on 11/08/24
+1.28 (+5.16%)
since 09/20/24

Most Recent Stories

More News
ArriVent BioPharma Reports Third Quarter 2024 Financial Results

AVBP : 26.09 (+1.72%)
Discover the 3 Best-Performing Biotech IPO Stocks of 2024

Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise.

UPB : 16.21 (-2.41%)
JNJ : 144.47 (+0.62%)
CGON : 28.67 (+2.32%)
AVBP : 26.09 (+1.72%)

Business Summary

ArriVent BioPharma Inc. is a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. ArriVent BioPharma Inc. is based in NEWTOWN SQUARE, Pa.

See More

Key Turning Points

3rd Resistance Point 28.24
2nd Resistance Point 27.46
1st Resistance Point 26.78
Last Price 26.09
1st Support Level 25.32
2nd Support Level 24.54
3rd Support Level 23.86

See More

52-Week High 36.37
Fibonacci 61.8% 27.96
Last Price 26.09
Fibonacci 50% 25.36
Fibonacci 38.2% 22.76
52-Week Low 14.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar